As with other insulin-resistant conditions, it remains unresolved whether the decreased insulin activity might be due to an intrinsic defect in the insulin signaling pathway, or is instead induced by environmental factors, which further prevent the evaluation of IR in PCOS, as well as the development of causal interventions [21]. This evidence concerns the gene INS and polycystic ovary syndrome.